Application of a Mapping Function to Estimate Utilities for Ragweed Allergy Immunotherapy Trials

Dick, Katherine; Briggs, Andrew; Brandi, Henrik

doi:10.1007/s41669-020-00205-y

Cited by 3 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, the Rhinitis Quality of Life Questionnaire measures quality‐of‐life in patients with AR but does not define health profiles that may be directly converted into utilities. 15 , 16 …”

Section: How Can Vandp Be Assessed?mentioning

confidence: 99%

See 1 more Smart Citation

Embedding patients' values and preferences in guideline development for allergic diseases: The case study of Allergic Rhinitis and its Impact on Asthma 2024

Vieira,

Sousa‐Pinto,

Bognanni

et al. 2024

Clinical & Translational All

View full text Add to dashboard Cite

Recommendations for or against the use of interventions need to consider both desirable and undesirable effects as well as patients' values and preferences (V&P). In the decision‐making context, patients' V&P represent the relative importance people place on the outcomes resulting from a decision. Therefore, the balance between desirable and undesirable effects from an intervention should depend not only on the difference between benefits and harms but also on the value that patients place on them. V&P are therefore one of the criteria to be considered when formulating guideline recommendations in the Evidence‐to‐Decision framework developed by the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) Working Group. Patients' V&P may be quantified through utilities, which can be elicited using direct methods (e.g., standard gamble or time trade‐off) or indirect methods (using validated instruments to measure health‐related quality of life, such as EQ‐5D). The GRADE approach recommends conducting systematic reviews to summarise all the available evidence and assess the degree of certainty on V&P. In this article, we discuss the importance of considering patients' V&P and provide examples of how they are considered in the 2024 person‐centred Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines.

show abstract

Section: How Can Vandp Be Assessed?mentioning

confidence: 99%

“…Importantly, not all quality‐of‐life instruments allow for the direct assessment of utility values. For example, the Rhinitis Quality of Life Questionnaire measures quality‐of‐life in patients with AR but does not define health profiles that may be directly converted into utilities 15,16 …”

Section: How Can Vandp Be Assessed?mentioning

confidence: 99%